Determination of angiotensin-converting enzyme concentration in cardiovascular patients
Keywords:
angiotensin, converting, enzyme concentration, cardiovascular, patientsAbstract
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year, More than four out of five CVD deaths are due to heart attacks and strokes, and one third of these deaths occur prematurely in people under 70 years of age . The circulating Renin Angiotensin Aldosterone system (RAAS) comprises liver - secreted angiotensinogen (AGT) that is enzymatically converted into angiotensin I (Ang I). ACE, as a key component in RAS, converts angiotensin I to angiotensin II, Angiotensin II increase the production of adhesion molecules and chemokines stimulates LDL oxidation and foam cell formation in macrophages, Increased level of the ACE and subsequent ACE activity by raising the production of angiotensin II can lead to atherosclerosis . A number of 100 subjects were involved in this investigation, 100 patients of CVDs in AL-Saddir Hospital and AL Hkem Hospital, in AL- Najaf province, 70 of them with CVDs and the other 30 healthy individuals, were used as control.The study was conducted to find out the importance of Determination of angiotensin-converting enzyme concentration in cardiovascular patients and some clinical and biochemical variables .
Downloads
References
World Health Organization. (2020). Hearts: technical package for cardiovascular disease management in primary health care.
Nehme, A., Zouein, F. A., Deris Zayeri, Z., & Zibara, K. (2019). An update on the tissue renin angiotensin system and its role in physiology and pathology. Journal of cardiovascular development and disease, 6(2), 14.
Bernstein, K. E., Ong, F. S., Blackwell, W. L. B., Shah, K. H., Giani, J. F., Gonzalez-Villalobos, R. A., ... & Fuchs, S. (2013). A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacological reviews, 65(1), 1-46.
Sztechman, D., Czarzasta, K., Cudnoch-Jedrzejewska, A., Szczepanska-Sadowska, E., & Zera, T. (2018). Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries. J Physiol Pharmacol, 69(6).
Nathaniel, S. D. (2020). Impact of Angiotensin Receptor–Neprilysin Inhibition on Cardiovascular Function. University of Delaware.
Rodgers, J. L., Jones, J., Bolleddu, S. I., Vanthenapalli, S., Rodgers, L. E., Shah, K., ... & Panguluri, S. K. (2019). Cardiovascular risks associated with gender and aging. Journal of cardiovascular development and disease, 6(2), 19.
Fleg, J. L., Forman, D. E., Berra, K., Bittner, V., Blumenthal, J. A., Chen, M. A., ... & Zieman, S. J. (2013). Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation, 128(22), 2422-2446.
Malik, R., Georgakis, M. K., Vujkovic, M., Damrauer, S. M., Elliott, P., Karhunen, V., ... & Gill, D. (2021). Relationship between blood pressure and incident cardiovascular disease: linear and nonlinear mendelian randomization analyses. Hypertension, 77(6), 2004-2013.
Son, J. S., Choi, S., Kim, K., Kim, S. M., Choi, D., Lee, G., ... & Park, S. M. (2018). Association of blood pressure classification in Korean young adults according to the 2017 American College of Cardiology/American Heart Association guidelines with subsequent cardiovascular disease events. Jama, 320(17), 1783-1792.
Tan, J., Zhang, X., Wang, W., Yin, P., Guo, X., & Zhou, M. (2018). Smoking, blood pressure, and cardiovascular disease mortality in a large cohort of Chinese men with 15 years follow-up. International journal of environmental research and public health, 15(5), 1026.
Zhou, D., Xi, B., Zhao, M., Wang, L., & Veeranki, S. P. (2018). Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study. Scientific reports, 8(1), 1-7.
Liu, Y., Ma, W., Zhang, P., He, S., & Huang, D. (2015). Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials. Clinical Nutrition, 34(1), 27-34.
Talayero, B. G., & Sacks, F. M. (2011). The role of triglycerides in atherosclerosis. Current cardiology reports, 13(6), 544-552.
Aberra, T., Peterson, E. D., Pagidipati, N. J., Mulder, H., Wojdyla, D. M., Philip, S., ... & Navar, A. M. (2020). The association between triglycerides and incident cardiovascular disease: what is “optimal”?. Journal of clinical lipidology, 14(4), 438-447.
Sun, C. J. (2021). Concordance and Discordance Between Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B as Cardiovascular Disease Risk Markers over the Full Spectrum of Hypertriglyceridemia: A Cross-sectional Analysis of Lipid Clinic Data (Doctoral dissertation, Université d'Ottawa/University of Ottawa).
Zhang, B., Kuipers, F., de Boer, J. F., & Kuivenhoven, J. A. (2021). Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles. Journal of clinical medicine, 11(1), 4.
Avci, E., Dolapoglu, A., & Akgun, D. E. (2018). Role of cholesterol as a risk factor in cardiovascular diseases. Cholesterol-Good, Bad and the Heart.
Ravnskov, U., Diamond, D. M., Hama, R., Hamazaki, T., Hammarskjöld, B., Hynes, N., ... & Sundberg, R. (2016). Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ open, 6(6), e010401.
Boren, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., ... & Ginsberg, H. N. (2020). Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European heart journal, 41(24), 2313-2330.
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., ... & Catapano, A. L. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European heart journal, 38(32), 2459-2472.
Rosenson, R. S., Brewer, H. B., Barter, P. J., Björkegren, J. L., Chapman, M. J., Gaudet, D., ... & Hegele, R. A. (2018). HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology. Nature Reviews Cardiology, 15(1), 9-19.
Casula, M., Colpani, O., Xie, S., Catapano, A. L., & Baragetti, A. (2021). HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role. Cells, 10(8), 1869.
Kim, J. H., Lim, S., Park, K. S., Jang, H. C., & Choi, S. H. (2017). Total and differential WBC counts are related with coronary artery atherosclerosis and increase the risk for cardiovascular disease in Koreans. PLoS One, 12(7), e0180332.
Haybar, H., Pezeshki, S. M. S., & Saki, N. (2019). Evaluation of complete blood count parameters in cardiovascular diseases: an early indicator of prognosis?. Experimental and molecular pathology, 110, 104267.
Lassale, C., Curtis, A., Abete, I., van der Schouw, Y., Verschuren, W. M., & Lu, Y. (2018). Elements of the complete blood count associated with cardiovascular disease incidence: findings from the EPIC-NL cohort study. Scientific reports, 8(1), 1-11.
Zhou, X., Zhang, P., Liang, T., Chen, Y., Liu, D., & Yu, H. (2020). Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1–7)-MAS axis and coronary heart disease. Heart and vessels, 35(2), 153-161.
Nouryazdan, N., Adibhesami, G., Birjandi, M., Heydari, R., Yalameha, B., & Shahsavari, G. (2019). Study of angiotensin-converting enzyme insertion/deletion polymorphism, enzyme activity and oxidized low density lipoprotein in Western Iranians with atherosclerosis: a case-control study. BMC cardiovascular disorders, 19(1), 1-9.
Gard, P. R. (2010). Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review. International journal of molecular epidemiology and genetics, 1(2), 145.
Pizoń, T., Rajzer, M., Wojciechowska, W., Wach-Pizoń, M., Drożdż, T., Wróbel, K., ... & Czarnecka, D. (2018). The relationship between plasma renin activity and serum lipid profiles in patients with primary arterial hypertension. Journal of the Renin-Angiotensin-Aldosterone System, 19(4), 1470320318810022.
Susilo, H., Pikir, B. S., Thaha, M., Alsagaff, M. Y., Suryantoro, S. D., Wungu, C. D. K., ... & Oceandy, D. (2022). Relationship Between ACE I/D Polymorphism and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease.
Ljungberg, L. (2009). Angiotensin-Converting Enzyme: Effects of Smoking and Other Risk Factors for Cardiovascular Diseases (Doctoral dissertation, Linköping University Electronic Press).
Ljungberg, L. U., & Persson, K. (2008). Effect of nicotine and nicotine metabolites on angiotensin-converting enzyme in human endothelial cells. Endothelium, 15(5-6), 239-245.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
